Top Markets
#1 Black Phoenix Black Phoenix +21,413.58%
#2 Nesa Nesa +772.51%
#3 Cortex Cortex +68.20%
#4 Kinesis Silver Kinesis Silver +55.45%
#5 Derive Derive +23.83%
#6 QuantixAI QuantixAI +23.80%
#7 EXOD EXOD +22.78%
#8 Cash Cat Cash Cat +15.96%
#9 Zest Protocol Zest Protocol +15.20%
#10 Alchemist AI Alchemist AI +14.78%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Rangering i aksjer #19184
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Aksjekurs
$4.62
Sist synkronisert: 2023-03-23
Markedsverdi
$171.76M
Endring (1 dag)
-37.16%
Endring (1 år)
0.00%
Land
KR
Handel Cellivery Therapeutics, Inc. (268600)

Kategori

Healthcare
Inntekter for Cellivery Therapeutics, Inc. (268600)
Inntekter i 2026 TTM: 0
Ifølge Cellivery Therapeutics, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Cellivery Therapeutics, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH